Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone and Exercise for Hip Fracture Recovery
NCT02938923Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2019
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Testosterone TEPI patch in Sarcopenia and frailty syndrome (3 arms), sponsored by Washington University School of Medicine. Primary endpoint: Change in Six Minute Walk Distance at 6 months. Started Mar 2019; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Sarcopeniafrailty syndrome
Beyond the preview
Go deeper on NCT02938923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02938923.